A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: Zr-89-Pt@TiO2-SPHINX, synthesis and in vitro evaluation
Articles > Article · 2021
Authors: Volkan Tekin, Tolulope Aweda, Özge KOZGUŞ GÜLDÜ, Fazilet Zümrüt BİBER MÜFTÜLER, Jennifer Bartels, Suzanne E. Lapi, Perihan ÜNAK
NUCLEAR MEDICINE AND BIOLOGY, Journal Indexed in SCI Expanded, International, 2021, vol 94-95, pp 20-31
DOI: 10.1016/j.nucmedbio.2020.12.005
Summary
Prostate cancer is the most common malignancy and leading cause of cancer deaths in men. Thus, the development of novel strategies for performing combined prostate cancer imaging and therapy methods is crucial and could have a significant impact on patient care.